Skip to main content
. 2017 Sep 12;8(60):101452–101460. doi: 10.18632/oncotarget.20843

Table 4. Signaling pathway analysis of the genetic interaction network associated with liver-aggressive explant in terms of Gene Ontology (GO).

Pathway ID Signaling pathway Observed Gene Count FDR
4010 MAPK signaling pathway 16 1.42E-12
4668 TNF signaling pathway 9 7.29E-08
5014 Amyotrophic lateral sclerosis (ALS) 7 1.26E-07
4750 Inflammatory mediator regulation of TRP channels 8 3.45E-07
4380 Osteoclast differentiation 8 1.45E-06
5140 Leishmaniasis 6 1.24E-05
4721 Synaptic vesicle cycle 5 0.000104
4664 Fc epsilon RI signaling pathway 5 0.000156
4660 T cell receptor signaling pathway 5 0.000787
5146 Amoebiasis 5 0.000993
4060 Cytokine-cytokine receptor interaction 7 0.00133
4722 Neurotrophin signaling pathway 5 0.00145
5160 Hepatitis C 5 0.00206
4015 Rap1 signaling pathway 6 0.00207
4911 Insulin secretion 4 0.00355
4728 Dopaminergic synapse 4 0.0148
5131 Shigellosis 3 0.0148
4370 VEGF signaling pathway 3 0.0155
5162 Measles 4 0.0162
5120 Epithelial cell signaling in Helicobacter pylori infection 3 0.0194
5222 Small cell lung cancer 3 0.0351
4064 NF-kappa B signaling pathway 3 0.0384
5168 Herpes simplex infection 4 0.0384
4723 Retrograde endocannabinoid signaling 3 0.0473

Abbreviations: FDR, false discovery rate; GO, Gene Ontology.